Loading clinical trials...
Loading clinical trials...
This randomized phase II trial studies how well surgical removal of the prostate and antiandrogen therapy with or without docetaxel work in treating men with newly diagnosed prostate cancer that has s...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Yale University
Collaborators
NCT02893917 · Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation, Castration-Resistant Prostate Carcinoma, and more
NCT03503344 · Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, and more
NCT03442556 · ATM Gene Mutation, BRCA1 Gene Mutation, and more
NCT02099864 · Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, and more
NCT03406858 · Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, and more
City of Hope
Duarte, California
University of California, Irvine
Irvine, California
University of Southern California
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions